Pharmacists petition CMS for Part D changes to long-term care

Share this article:

The American Society of Consultant Pharmacists and five other healthcare groups are recommending the government make several policy changes to the Medicare Part D program. The purpose is to resolve medication access problems for long-term care residents.

The groups petitioned Mark B. McClellan, administrator of the Centers for Medicare & Medicaid Services, for the changes. Recommendations include: Allowing physicians to use a form to request non-formulary medication or prior authorization, and prohibiting Part D plans from imposing formulary restrictions or prior authorization requirements at the time of initial fill.

The requests stem from problems related to residents' accessibility to medications during the launch of the program. Pharmacists accused the plans of imposing prior authorization requirements on entire categories of medications. They also complain the large variability among Part D plans creates obstacles to providing quality of care to long-term care residents.

Other groups that signed on to the ASCP letter are: the American Association for Geriatric Psychiatry, the American Geriatrics Society, the American Psychiatric Association, the Maine Benzodiazepine Study Group and the National Association Directors of Nursing Administration/Long Term Care.
Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.